These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3737785

  • 1. Does the cholecystokinin antagonist proglumide possess antipsychotic activity?
    Innis RB, Bunney BS, Charney DS, Price LH, Glazer WM, Sternberg DE, Rubin AL, Heninger GR.
    Psychiatry Res; 1986 May; 18(1):1-7. PubMed ID: 3737785
    [Abstract] [Full Text] [Related]

  • 2. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
    Whiteford HA, Stedman TJ, Welham J, Csernansky JG, Pond SM.
    J Clin Psychopharmacol; 1992 Oct; 12(5):337-40. PubMed ID: 1362205
    [Abstract] [Full Text] [Related]

  • 3. Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
    Piolti R, Appollonio I, Perego M, Pozzi C, Rovati L, Ferrarese C, Frattola L.
    Eur Neurol; 1995 Oct; 35(6):344-8. PubMed ID: 8591802
    [Abstract] [Full Text] [Related]

  • 4. A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics.
    Hicks PB, Vinogradov S, Riney SJ, Su K, Csernansky JG.
    J Clin Psychopharmacol; 1989 Jun; 9(3):209-12. PubMed ID: 2567742
    [Abstract] [Full Text] [Related]

  • 5. The influence of proglumide, a putative CCK antagonist, on cerebral ischemia in gerbil.
    Xu C, Xue D, Su MC, Du LF, Gu X, Yang CL, Liu F.
    Peptides; 1987 Jun; 8(5):769-72. PubMed ID: 3432123
    [Abstract] [Full Text] [Related]

  • 6. Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
    Bunney BS, Chiodo LA, Freeman AS.
    Ann N Y Acad Sci; 1985 Jun; 448():345-51. PubMed ID: 2862828
    [No Abstract] [Full Text] [Related]

  • 7. Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system.
    Chiodo LA, Bunney BS.
    Science; 1983 Mar 25; 219(4591):1449-51. PubMed ID: 6828873
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide.
    Chiodo LA, Freeman AS, Bunney BS.
    Brain Res; 1987 May 05; 410(2):205-11. PubMed ID: 3036308
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR, Kinscheck IB, Mayer DJ.
    Brain Res; 1985 Feb 18; 327(1-2):169-80. PubMed ID: 3838690
    [Abstract] [Full Text] [Related]

  • 10. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward.
    Vaccarino FJ, Vaccarino AL.
    Neurosci Lett; 1989 Feb 13; 97(1-2):151-6. PubMed ID: 2918999
    [Abstract] [Full Text] [Related]

  • 11. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G, Davison JS.
    Am J Physiol; 1987 Feb 13; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [Abstract] [Full Text] [Related]

  • 12. Cholecystokinin-8 and proglumide modulation of electrically elicited eating.
    Schneider LH.
    Prog Clin Biol Res; 1985 Feb 13; 192():123-30. PubMed ID: 4080705
    [Abstract] [Full Text] [Related]

  • 13. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
    Pfaus JG, Phillips AG.
    Eur J Pharmacol; 1987 Sep 23; 141(3):331-8. PubMed ID: 3666030
    [Abstract] [Full Text] [Related]

  • 14. The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain.
    McCleane GJ.
    Anesth Analg; 1998 Nov 23; 87(5):1117-20. PubMed ID: 9806692
    [Abstract] [Full Text] [Related]

  • 15. Structural features of various proglumide-related cholecystokinin receptor antagonists.
    Jensen RT, Zhou ZC, Murphy RB, Jones SW, Setnikar I, Rovati LA, Gardner JD.
    Am J Physiol; 1986 Dec 23; 251(6 Pt 1):G839-46. PubMed ID: 2431626
    [Abstract] [Full Text] [Related]

  • 16. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G, Hsiao S, Itoh S.
    Peptides; 1984 Dec 23; 5(3):529-34. PubMed ID: 6089145
    [Abstract] [Full Text] [Related]

  • 17. The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat.
    Collins S, Walker D, Forsyth P, Belbeck L.
    Life Sci; 1983 May 09; 32(19):2223-9. PubMed ID: 6843294
    [Abstract] [Full Text] [Related]

  • 18. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 19. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
    Verspohl EJ, Wunderle G, Ammon HP, Williams JA, Goldfine ID.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar 21; 332(3):284-7. PubMed ID: 3012373
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG, Glick S, Mellentin J.
    Psychopharmacology (Berl); 1987 Mar 21; 91(4):440-4. PubMed ID: 3108924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.